Stock listing

Regenxbio Inc.

Selected listing: A140E0 · LS · EUR · DE

Regenxbio Inc. (Lang & Schwarz: A140E0), Health Technology. Latest release Sep 24, 2026: REGENXBIO Presents Positive Three-Year Durability Data for Surabgene…

A140E0:LSEURDEUpdated September 25, 2026

Ticker: Lang & Schwarz: A140E0
Asset type: Stock
Sector: Health Technology
Industry: Pharmaceuticals: Major
Exchange: Lang & Schwarz
Currency: EUR

About Regenxbio Inc.

Regenxbio Inc. (RGNX) is listed on 6ix with investor news, events, company updates, and market data in one place. Follow the company page to track new releases, upcoming presentations, and the latest information available on 6ix.

Latest news from Regenxbio Inc.

REGENXBIO Presents Positive Three-Year Durability Data for Surabgene Lomparvovec in Diabetic Retinopathy at Retina Society Annual Scientific Meeting

September 24, 2026

REGENXBIO Strengthens Board of Directors with Appointment of Greg Ciongoli

August 25, 2026

REGENXBIO : Announces Regulatory Update on RGX-121 for MPS II

August 24, 2026

REGENXBIO Announces Regulatory Update on RGX-121 for MPS II

August 24, 2026

REGENXBIO Reports Second Quarter 2026 Financial Results and Operational Highlights

August 6, 2026

All Regenxbio Inc. news →

Events

Replays

REGENXBIO Inc. (RGNX) Q2 2026 Earnings Call
Thu, Aug 06, 2026 · 08:00 AM ET
Watch
REGENXBIO Inc. (RGNX) Q1 2026 Earnings Call
Thu, May 14, 2026 · 08:00 AM ET
Watch
REGENXBIO Inc. (RGNX) Q4 2025 Earnings Call
Thu, Mar 05, 2026 · 08:00 AM ET
Watch

Research Regenxbio Inc.

Regenxbio Inc. company profile

View the public company page for Regenxbio Inc. on 6ix.

Regenxbio Inc. news

Read company news and market updates connected to Regenxbio Inc..

Regenxbio Inc. investor events

Find investor webinars, events, and replay context for Regenxbio Inc..